Search

everythinglearnresearchcommunity

for

Search:↓

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Low zinc levels may be linked to the return of gynecologic cancers.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Metformin helps improve menstrual irregularities and some hormone levels in PCOS patients, but not symptoms like excess hair, acne, or hair loss.

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

No definitive link between finasteride and male breast cancer, but further research is needed.

A systematic approach is crucial for managing hair loss in women.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Urinary Se to creatinine ratio, serum Se, and glutathione peroxidase are effective early biomarkers for selenium status in dogs.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Oxidative stress is linked to mild patchy alopecia areata.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.